Revenue
2021
2022
2023
2024
Amplitude Surgical (AMPLI)
Price—Loading quote
Net income
2021
2022
2023
2024
Free cash flow
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue | €106.0M | €100.2M | €87.6M | €82.7M |
| Operating income | €10.3M | €8.1M | €4.9M | −€1.7M |
| Operating margin | 9.68% | 8.03% | 5.64% | −2.00% |
| Net income | €1.5M | €38.5M | −€4.8M | −€14.7M |
| Net profit margin | 1.44% | 38.45% | −5.48% | −17.73% |
| Basic EPSper basic share | €0.03 | €0.82 | -€0.09 | -€0.30 |
| Diluted EPSper diluted share | €0.03 | €0.82 | -€0.09 | -€0.29 |
Owners
Reported shareholders and owner groups
75.36%of company shares
Auroralux SASSource updated Aug 11, 2025
View holders
| Holder | Ownership |
|---|---|
Auroralux SAS | 75.36%Aug 11, 2025 |
Zydus MedTech SAS | 10.20%Aug 11, 2025 |
SC Scerac | 1.74%Aug 11, 2025 |
Raphaël Motte | 1.03%Aug 11, 2025 |
ICBT Groupe | 0.70%Aug 11, 2025 |
Bernard Terrat | 0.44%Aug 11, 2025 |
Elise Motte | 0.33%Aug 11, 2025 |
Nathalie Delozière | 0.21%Aug 11, 2025 |
Vincent Delozière | 0.21%Aug 11, 2025 |
These Euronext company-profile figures report shares in the company's capital. Named holders and owner groups are shown as published; free float, treasury shares, and unspecified holders are excluded from the colored segments.
Gray completes the 100% scale; it is not an estimate of other owners.
Source: Euronext / Cofisem ↗Checked Oct 21, 2026